Aim of this study was to compare cerebrospinal fluid (CSF) virological control, biomarkers and neurocognition of neurologically symptomatic patients on dual antiretroviral therapies (DT) versus 2NRTIs-based three-drug regimens (TT).
Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV
Calcagno, Andrea
2020-01-01
Abstract
Aim of this study was to compare cerebrospinal fluid (CSF) virological control, biomarkers and neurocognition of neurologically symptomatic patients on dual antiretroviral therapies (DT) versus 2NRTIs-based three-drug regimens (TT).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Dual CSF Trunfio AIDS 2020 postprint.pdf
file disponibile solo agli amministratori
Licenza:
DRM non definito
Dimensione
582.82 kB
Formato
Adobe PDF
|
582.82 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
